Editorial · 30 May 2025
Conference abstractPublished 21 Jul 2014
Differential inhibition of PDKs by phenylbutyrate and identification of putative binding sites
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pyruvate dehydrogenase kinase (PDK) isoforms are molecular switches that downregulate the pyruvate dehydrogensase complex (PDC) by reversible phosphorylation in mithocondria. To date, four PDK isoforms (PDK1-4) have been identified in humans, each of them is able to phosphorylate (and inactivate) the complex exhibiting different site specificity. The expression of the four PDK isoforms is tissue specific in response to needs of various tissues under different metabolic conditions. Indeed, their activity on PDC is an important switch that regulates both diabetes (PDK2/PDK4) and cancer metabolism (PDK1/ PDK3).So far, several molecules have been investigated to inhibit PDK activity but none of them fulfils the requirements for a safe and effective drug: strength, specificity, and absence of toxic effects. The author and her team has recently discovered that phenylbutyrate (PB) is effective in activating the PDC by direct inhibition of PDK2 and is effective at improving a rare inborn error of metabolism due to PDC deficiency.In this it has been investigated phenylbutyrate inhibiting activity towards the other PDK isoenzymes (PDK1, 3 and 4) using suitable functional assays. Also, by using molecular docking, we have identified putative binding sites of PB on each PDK isoform suggesting molecular determinants of enzyme selectivity. The information gained from these studies give important insights on the molecular determinants in PDK inhibition and allows designing specific PDKs inhibitor. Also, because PB is already approved for human use in other diseases, the findings of this study have the potential to be rapidly translated into clinics.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Clara Iannuzzi”
- BylineArticles whose byline prints “Rosa Ferriero”
- BylineArticles whose byline prints “Peter Stacpoole”
- BylineArticles whose byline prints “Nicola Brunetti-Pierri”
- BylineArticles whose byline prints “Giuseppe Manco”